Moreover, modulation of adverse immune processes could be dampened via the observed shift of CD14+ cells into a pro-regenerative phenotype and the enhanced induction of regulatory T cells in selected autoimmune diseases, such as diabetes or arthritis. The gene discussed is CD14; the disease is autoimmune disease.